StockData
Phio Pharmaceuticals Corp. logo

Phio Pharmaceuticals Corp. (PHIO) stock

PHIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$0.81−0.00 (-0.17%)

Close on Nov 12, 2026Market cap $9.43MP/E –Yield –

Phio Pharmaceuticals statistics

59 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Mar 4, 2027 (estimated, after the close)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 12, 2026

Valuation ratiosIndustry

Market Cap
$9.43M
$280.48M
Enterprise Value
-$1.18M
$148.62M
PB Ratio
1.09
2.05
P/TBV Ratio
1.09
2.29

Share statisticsIndustry

Shares Change (YoY)
181.9%
10.9%
Shares Change (QoQ)
2.88%
0.48%
Float
10M
49M
Shares Held by Insiders
10.7%
12.1%
Shares Held by Institutions
5.57%
56.4%

Short sellingIndustry

Short Interest
86,344
–
Short Interest Change
-36.7%
-0.76%
Short % of Float
0.83%
9.06%
Short % of Shares Outstanding
0.74%
6.30%
Days to Cover
1.49
5.13

Stock price statisticsIndustry

52-Week High
$1.88
–
52-Week Low
$0.75
–
20-Day Moving Average
$0.86
–
50-Day Moving Average
$0.95
–
200-Day Moving Average
$1.08
–
Average True Range (14)
$0.06
–
Price Change (1 Week)
1.47%
1.51%
Price Change (1 Month)
-14.5%
-2.37%
Price Change (3 Months)
-25.5%
-21.1%
Price Change (6 Months)
-27.5%
-22.8%
Price Change (YTD)
-22.7%
-22.6%
Price Change (1 Year)
-49.6%
-21.0%
Price Change (3 Years)
-91.2%
-24.8%
Price Change (5 Years)
-99.5%
-76.9%
Price Change (10 Years)
-100.0%
-63.2%
Average Volume (10 Days)
71,485
–
Average Volume (20 Days)
64,768
–
Average Volume (90 Days)
435,495
–
Relative Volume
0.16
0.80
Relative Strength Index (14)
37.3
44.7
Volatility (1 Year)
78.2%
80.2%
Beta (5 Years)
1.38
1.07

Returns on capitalIndustry

Return on Equity (ROE)
-159.0%
-51.3%
Return on Assets (ROA)
-128.6%
-40.7%

EfficiencyIndustry

Profits Per Employee
-$2.45M
-$683.67K
Employee Count
6
75
WACC
11.8%
10.0%

Income statement (TTM)Industry

Operating Income
-$15.24M
-$20.99M
Net Income
-$14.67M
-$21.61M
EBITDA
-$15.23M
-$16.85M
EPS (Diluted)
-$1.31
-$0.75

Balance sheetIndustry

Net Cash (Debt)
$10.61M
$16.98M
Net Cash Per Share
$0.91
$0.72
Equity (Book Value)
$8.62M
$52.68M
Book Value Per Share
$0.74
$1.50
Tangible Book Value
$8.62M
$26.74M

Cash flow (TTM)Industry

Operating Cash Flow
-$12.40M
-$12.27M
Capital Expenditures
$0
-$944.00K
Free Cash Flow
-$12.40M
-$18.20M
FCF Per Share
-$1.07
-$0.42

Dividends and yieldsIndustry

Earnings Yield
-155.6%
-21.0%
FCF Yield
-131.5%
-9.44%

Scores and fair valueIndustry

Altman Z-Score
-23.05
0.26

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodPHIOS&P 500DifferencePHIO per yearS&P 500 per year
1 month-12.0%-2.7%−9.3 pts
3 months-24.8%-1.7%−23.1 pts
Year to date-22.7%+11.9%−34.6 pts
1 year-48.6%+12.0%−60.6 pts
3 years-91.6%+78.2%−169.8 pts-56.3%+21.2%
5 years-99.5%+73.2%−172.8 pts-65.6%+11.6%
10 years-100.0%+309.6%−409.6 pts-68.1%+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M PHIO shares were sold short on Oct 30, 2026, down 36.7% from the previous report, or 0.83% of the shares available to trade. At recent volumes it would take 1.5 days to buy them back. Over the last 20 sessions, 48.1% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202686,344-36.7%57,8671.5
Oct 15, 2026136,375+52.5%91,8701.5
Sep 30, 202689,454-40.3%114,5951.0
Sep 15, 2026149,890-32.3%155,8061.0
Aug 31, 2026221,546-30.7%222,9941.0
Aug 14, 2026319,747+11.3%121,4392.6
Jul 31, 2026287,349+61.8%305,6191.0
Jul 15, 2026177,615-18.8%2,616,8991.0
Jun 30, 2026218,725-27.7%241,4921.0
Jun 15, 2026302,481-3.6%153,8742.0
May 29, 2026313,798-5.4%106,0653.0
May 15, 2026331,567-29.4%177,2651.9

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?